--- title: "Merck and Moderna's personalized cancer vaccine shows success in late-stage melanoma trial" description: "Most outlets led with the success of Merck and Moderna’s personalized cancer vaccine in a late-stage melanoma trial, emphasizing its potential to curb cancer recurrence. The News International highlighted the trial as the first-ever for melanoma, while 24 News HD focused on the drug’s tailored approach and its effect on preventing recurrence. Both outlets used similar framing but varied slightly in emphasis and phrasing." url: https://harzaviya.com/stories/3930-merck-and-moderna-s-tailored-cancer-drug-curbs-melanoma site: HarZaviya language: en --- # Merck and Moderna's personalized cancer vaccine shows success in late-stage melanoma trial health · latest filing 20 Aug 2026, 11:19 AM PKT · 19–20 Aug 2026 · 4 articles from 4 outlets **HarZaviya summary** — how 4 outlets covered this, generated automatically from their headlines and excerpts: > Most outlets led with the success of Merck and Moderna’s personalized cancer vaccine in a late-stage melanoma trial, emphasizing its potential to curb cancer recurrence. The News International highlighted the trial as the first-ever for melanoma, while 24 News HD focused on the drug’s tailored approach and its effect on preventing recurrence. Both outlets used similar framing but varied slightly in emphasis and phrasing. ## Same story from 4 outlets Each outlet's own headline, most recent first — read any at its source. - **Geo News** — [Tailored cancer drug curbs melanoma recurrence in trial](https://www.geo.tv/latest/678421-tailored-cancer-drug-curbs-melanoma-recurrence-in-trial) · 20 Aug 2026, 11:19 AM PKT > Employees train to be cell therapy specialists at Gilead unit Kite's manufacturing facility in Frederick Maryland, US, March 14, 2024. — Reuters US drugmakers Merck and Moderna said on Wednesday an experimental melanoma drug that delivers treatment tailored to a patient's... - **Arab News Pakistan** — [‘Breakthrough’ mRNA cancer drug curbs melanoma in large trial](https://www.arabnews.pk/node/2655270/world) · 20 Aug 2026, 7:08 AM PKT · 71% identical wording to the newest filing > WASHINGTON: US drugmakers Merck and Moderna said Wednesday a personalized cancer treatment had shown success in reducing the recurrence of melanoma tumors in a late-stage trial hailed by experts as a “breakthrough.” The news sent shares in Moderna soaring 145 percent to $154 while Merck’s stock was up more than 12 percent to $152. The drug, called “intismeran autogene,” is based on the same mes... - **24 News HD** — [Merck and Moderna's tailored cancer drug curbs melanoma recurrence in trial](https://www.24newshd.tv/20-Aug-2026/merck-moderna-s-tailored-cancer-drug-curbs-melanoma-recurrence-trial) · 20 Aug 2026, 12:22 AM PKT · 84% identical wording to the newest filing > US drugmakers Merck and Moderna said Wednesday an experimental melanoma drug that delivers treatment tailored to a patient's specific tumor prevented the cancer from returning in a large clinical trial. - **The News International** — [Moderna, Merck 'personalized' cancer vaccine succeeds in late-stage melanoma trial](https://www.thenews.com.pk/latest/1412794-moderna-merck-personalized-cancer-vaccine-succeeds-in-late-stage-melanoma-trial) · 19 Aug 2026, 4:48 PM PKT · 69% identical wording to the newest filing > Moderna, Merck ‘personalized’ cancer vaccine succeeds in late-stage melanoma trial Merck and Moderna’s experimental personalized cancer vaccine has shown promising success in Melanoma’s first-ever late-stage trial. The landmark success in the trial has brought the... 4 articles from 4 outlets, 19–20 Aug 2026. Headlines and links belong to their outlets — HarZaviya links out and never copies article text. --- HarZaviya compares how Pakistani outlets cover the same story. It stores and shows each outlet's headline and a short excerpt, and links out — it never copies article text, and every headline belongs to the outlet that wrote it. It takes no stance on any outlet. Pages: [Top stories](https://harzaviya.com/) · [Latest headlines](https://harzaviya.com/feed) · [Archive](https://harzaviya.com/archive) · [Why](https://harzaviya.com/why) · [Sources](https://harzaviya.com/sources) · [Methodology](https://harzaviya.com/methodology) · [About](https://harzaviya.com/about) · [About the bot](https://harzaviya.com/about-bot) Trackers: [Gold prices](https://harzaviya.com/gold-prices) · [Fuel prices](https://harzaviya.com/fuel-prices) · [Stock exchange](https://harzaviya.com/stock-exchange) Any page on this site is available as markdown: send `Accept: text/markdown`, or add `.md` to the path.